This was Dec 2019, now LexaGene is to market. And look at pic, they have made MiQLab smaller.
How rare that is, a nanocap geting covered by Forbes.
New artcile on it on Seeking Alpha: Is LexaGene The Perfect Stock?
Conclusion The PCR medical testing sector is a wonderful business with very high stock market valuations and buyout valuations. It is recession resistant, in fact the best year ever for PCR was the recession of 2020. LexaGene's MiQLab is a breakthrough product in terms of cost, ease of use, and open access. Am expecting that the FDA will approve it in 2021 for human POC and that LexaGene will be able to generate multiple millions in revenue within a year. Believe that will result in a 10 bagger or better, which would be $8 a share. Can find nothing wrong with this company after studying it for a week. So the answer the question in the title, yes LexaGene is the perfect stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.